5/24/2023
RedChip Logo

RedChip Companies

Weekly Newsletter
 

BioVie Presents Rationale for Potentially Pivotal Trial of NE3107 in the Treatment of Parkinson’s Disease at 2023 International Association of Parkinsonism and Related Disorders World Congress

BioVie (Nasdaq: BIVI), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, announced that a poster detailing the supporting data and rationale for a potentially pivotal clinical trial of NE3107 in the treatment of Parkison’s Disease was presented at the 2023 World Congress on Parkison’s Disease and Related Disorders (IAPRD), held in Chicago, IL May 13-16, 2023.

For more information, visit www.bioviepharma.com

 
See More Info
 
 
 

Reviv3 Procare Subsidiary Signs Multi-Year Licensing Agreement with NASCAR

Reviv3 Procare (OTCQB: RVIV) wholly owned subsidiary Reeviv3 Acquisition Corp. entered into a multi-year licensing agreement with NASCAR. Under the terms of the agreement, Reviv3 will produce and sell a new line of NASCAR-branded earbuds, earmuffs, hearing devices, ear plugs, and outdoor speakers in NASCAR venues and distribution channels in the US, Puerto Rico, and Canada, as well as at US military bases around the world.

 
Learn More
   

KWESST Provides Update on CFO Replacement, Defence Contracts in Progress, Upcoming Participation at CANSEC, and Confirms Filing of Q2 Financials

KWESST Micro Systems (Nasdaq: KWE) updated shareholders on its search for a permanent CFO, the potential increase in scope and value of two of its defense contracts, it's participation at the annual Canadian defence show in Ottawa, and confirmed filing of its financial results for Q2 of Fiscal 2023.

 
Learn More
 

Soligenix Announces European Patent Grant for Use of Dusquetide in Oral Mucositis

Soligenix (Nasdaq: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced that the European Patent Office has granted a patent entitled "Novel Peptides and Analogs for Use in the Treatment of Oral Mucositis".  This granted patent builds on similar intellectual property issued in the United States (U.S.), New Zealand, Japan, Australia and Singapore, as well as many pending patent applications in other jurisdictions worldwide. The granted claims will cover therapeutic uses of dusquetide (active ingredient in SGX942) and related innate defense regulator (IDR) analogs, and adds to composition of matter claims for dusquetide and related analogs that have been issued in the U.S. and worldwide.

 
Learn More
 

Genius Group Shareholders Approve Spin Off of Entrepreneur Resorts Limited and New Constitution

Genius Group (NYSE American: GNS), a leading entrepreneur edtech and education group, held an Extraordinary General Meeting on May 16, 2023, approving the adoption of a new constitution and spin off of Entrepreneur Resorts Limited to shareholders. Roger Hamilton, CEO of Genius Group, said, “The Board thanks Genius Group’s shareholders for passing those two resolutions which will enable Genius Group and Entrepreneur Resorts Limited’s management teams to streamline operations and focus on their respective business models more effectively.”

 
Learn More
 

 
 

Upcoming Events

25

May

2023

NASDAQ: SNGX - Soligenix
4:15pm Eastern
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need.
 
Sign Up
 

30

May

2023

NASDAQ: LTRN - Lantern Pharma
4:15pm Eastern
Lantern Pharma is a clinical stage oncology-focused company who is harnessing the power of Artificial Intelligence and Genomics to develop precision cancer therapies.
 
Sign Up
 

1

June

2023

NYSE American: GNS - Genius Group
11:00am Eastern
Genius Group is a world leading entrepreneur Edtech and education group, with a mission to disrupt the current education model with a student-centered, life-long learning curriculum that prepares students with the leadership, entrepreneurial and life skills to succeed in today’s market.
 
Sign Up
 

1

June

2023

NASDAQ: STSS - Sharps Technology
4:15pm Eastern
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems.
 
Sign Up
 

6

June

2023

NASDAQ: ALAR - Alarum Technologies
11:00am Eastern
Alarum Technologies Ltd. is an Israel-based company engaged in the information security business. It controls and secures data exchange, preventing data exfiltration, leakage, malware, ransomware, and fraud.
 
Sign Up
 

6

June

2023

NASDAQ: BFRG - BullFrog AI
4:15pm Eastern
BullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine.
 
Sign Up
 

28

June

2023

NASDAQ: ASPI - ASP Isotopes
4:15pm Eastern
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries.
 
Sign Up
 
 
 

Archive Events

18

May

2023

NASDAQ: BIVI - BioVie
Meeting Duration 43 minutes
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease.
 
Watch Replay
 

10

May

2023

NASDAQ: BFRG - BullFrog AI
Meeting Duration 35 minutes
BullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine.
 
Watch Replay
 

5

May

2023

NASDAQ: UNCY - Unicycive Therapeutics
Meeting Duration 28 minutes
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions.
 
Watch Replay
 

3

May

2023

NASDAQ: ASPI - ASP Isotopes
Meeting Duration 32 minutes
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries.
 
Watch Replay
 

27

April

2023

NASDAQ: GENE - Genetic Technologies Limited
Meeting Duration 30 minutes
Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health.
 
Watch Replay
 

20

April

2023

NASDAQ: IINN - Inspira Technologies
Meeting Duration 38 minutes
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure.
 
Watch Replay
 

19

April

2023

NASDAQ: ALAR - Alarum Technologies
Meeting Duration 37 minutes
Alarum Technologies Ltd. is an Israel-based company engaged in the information security business. It controls and secures data exchange, preventing data exfiltration, leakage, malware, ransomware, and fraud.
 
Watch Replay
 

18

April

2023

NASDAQ: RVSN - Rail Vision
Meeting Duration 44 minutes
Rail Vision is the leading provider of obstacle detection and classification systems in the railway industry.
 
Watch Replay
 

13

April

2023

NASDAQ: ARDS - Aridis Pharmaceuticals
Meeting Duration 40 minutes
Aridis Pharmaceuticals, Inc. discovers and develops novel anti-infective therapies to treat life-threatening infections, including anti-infectives to be used as add-on treatments to standard-of-care antibiotics.
 
Watch Replay
 

11

April

2023

NASDAQ: DGLY - Digital Ally
Meeting Duration 31 minutes
Digital Ally Companies is a diversified holding company with operations in video solution technology, human and animal health protection products, healthcare revenue cycle management, ticket brokering and marketing, and event production.
 
Watch Replay
 
 
 

Lesson of the Week

Management is the first fundamental to consider when evaluating smaller-cap companies.

 
Learn More
 
 
 
 

RedChip TV

This Week on RedChip TV: Two Nasdaq-Listed Stocks All Investors Should Know

Soligenix: Rising to the Challenges of Rare Disease Treatment

BioVie's Novel Approach in the Battle Against Alzheimer's and Parkinson's

Aiming to Revolutionize Mechanical Ventilation” to “Aiming to Revolutionize Acute Respiratory Care

Genius Group: Disrupting the $10 Trillion Global Education Market

Continental Lithium: Addressing the Rapidly Increasing Global Demand for Lithium

Revolutionizing Precision Medicine: BullFrog's AI-Powered Drug Development Platform Leads the Charge

Alarum Technologies: Identifies and Eliminates Online Threats

Reviv3 ProCare’s AXIL Brand Delivers Explosive Revenue Growth in BEST IN CLASS Hearing Protection

Reviva: Phase 3 Trial in Schizophrenia Now Underway

ASP Isotopes: Commercialization of Next-Generation Isotope Enrichment Technology

Aridis Pharmaceuticals: Reporting Positive Top-Line Results from Phase 2a Study in Cystic Fibrosis

Sharps Technology: Targeting Niche, Multi-Billion-Dollar Markets

 
 

MidSouth Week in Review

The inflation rate came out at 4.9%, the lowest rate since April 2021.

 
Learn More
 

You are receiving this email because your email is subscribed to our mailing list.
Click here to update your subscription or unsubscribe your email address.
Copyright © 2023. All rights reserved.
© 2023 RedChip , All rights reserved